Lutein 5%
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
400 mg
Serving Size
250
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
20 mg
📊 Market median: 10.0mg (105 products)
📚 1 studies (Tier A: 0, B: 1)
Other Ingredients
Maltodextrin
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (87% of products)
Nutrient (18% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Product Information
📋 Directions for Use
Suggested use: As a dietary supplement, take 400 mg (about 1/6 tsp) once daily, or as directed by a physician.
⚠️ Warnings & Precautions
Always consult a physician before taking any dietary supplement.
Keep out of reach of children.
🧪 Formulation Notes
Free of: Soy, dairy, yeast, gluten
Additional Information
Store in a dry, cool, dark place. Contents sold by weight, not volume. Settling may occur.
New Use an accurate milligram scale.
Product Details
UPC / SKU
X000IXQ73J
DSLD Entry Date
2024-06-20
Product Type
Non-Nutrient/Non-Botanical
Form
Powder
Brand
BulkSupplements.com
DSLD ID
312297
Data Updated
2026-04-11
Research Evidence
8
Research Sources
46
Avg Quality Score
4
Rct
2
Clinical Trial
1
Systematic Review
C
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18
C
Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study.
C
Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial.
C
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
C
The Influence of Lutein Supplements on Age-related Macular Degeneration
D
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
D
Lutein
